市场调查报告书
商品编码
1576661
连续血糖监测市场规模、占有率、预测、趋势分析:按组件(感测器[一次性、植入式]、接收器、发射器)、按年龄组(成人、儿童)、按最终用户(家庭护理、医院和诊所)-世界预计到 2031 年Continuous Glucose Monitoring Market Size, Share, Forecast, and Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics) - Global Forecast to 2031 |
预计到 2031 年,全球连续血糖监测市场将达到 314.1 亿美元,2024 年至 2031 年复合年增长率为 15%。
经过广泛的二次和初步研究以及对市场情景的详细分析,本报告对关键行业驱动因素、限制因素、课题和机会进行了分析。连续血糖监测(CGM)市场的成长是由人们生活方式的变化、糖尿病等慢性病负担的增加、CGM相对于传统血糖监测的优势以及运动员和运动员对CGM不断增长的需求推动的。带动。然而,CGM 设备的高成本和产品召回限制了该市场的成长。
此外,CGM 设备的技术进步、个人化护理的转变、健康意识的提高以及新兴国家糖尿病护理设备的可及性的提高预计将为市场增长创造机会。然而,大量未确诊的糖尿病患者以及与 CGM 设备的黏附性、可靠性和准确性相关的问题是全球连续血糖监测市场的主要课题。
(註:提供上位5公司的SWOT分析)
Continuous Glucose Monitoring Market Size, Share, Forecast, and Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics)-Global Forecast to 2031
The global continuous glucose monitoring market is projected to reach $31.41 billion by 2031 at a CAGR of 15% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the continuous glucose monitoring (CGM) market is driven by lifestyle changes among the population coupled with the growing burden of chronic conditions such as diabetes, the benefits offered by CGM over conventional glucose monitoring, and the use of CGM by athletes and fitness enthusiasts. However, high costs and product recalls of CGM devices restrain the growth of this market.
Furthermore, technological advancements in CGM devices, a shift toward personalized care and, rising health awareness, and increasing accessibility for diabetes care devices in developing countries are expected to generate market growth opportunities. However, the high number of people living undiagnosed with diabetes patients and problems related to the adhesiveness, reliability, and accuracy of CGM devices are major challenges in the global continuous glucose monitoring market.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the continuous glucose monitoring market are DexCom, Inc. (US), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (UK), LifeScan, Inc. (US), Senseonics Holdings, Inc. (U.S.), A. Menarini Diagnostics S.r.l (Italy), Medtrum. Technologies, Inc. (Shanghai.), and B. Braun SE (Germany).
Among all the components studied in this report, in 2024, the sensors segment is expected to account for the largest share of 52.4% of the continuous glucose monitoring market. The sensors segment is further segmented into disposable sensors and implantable sensors. The large market segment is attributed to the high demand for continuous glucose monitoring and frequent purchases of sensors compared to receivers and transmitters. Sensors require more frequent replacement compared to other components. Disposable sensors are replaced in 7 to 14 days after placement while implantable sensors can be replaced in 150-180 days.
Among all the age groups studied in this report, in 2024, the adult segment is expected to account for a larger share of the continuous glucose monitoring market. This segment's large market share can be attributed to the high proportion of the geriatric population with diabetes and changing lifestyles leading to diseases such as obesity, depression, anxiety, and cardiovascular diseases.
Among all the end users studied in this report, in 2024, the home care settings segment is expected to account for a larger share of 82.3% of the continuous glucose monitoring market. The large market share of this segment is attributed to factors such as the high prevalence of diabetes worldwide, rising awareness among people, a shift toward preventive healthcare, and easy accessibility to CGM in developed countries. CGM technologies provide numerous advantages in home care settings. There is a growing shift toward home healthcare due to the lack of healthcare professionals and increasing consumer awareness regarding the monitoring of diabetic conditions through CGM, which supports the large market share of the segment.
An in-depth analysis of the geographical scenario of the global continuous glucose monitoring market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of 17.4% during the forecast period. The market growth of this region is attributed to the advancing healthcare infrastructure, growing disposable income, and rising investments by major key market players. Furthermore, economic growth, as well as technological developments support the market growth in Asia-Pacific.
Continuous glucose monitoring Market Assessment-by Component
Continuous glucose monitoring Market Assessment-by Age Group
Continuous glucose monitoring Market Assessment-by End User
Continuous glucose monitoring Market Assessment-by Geography
(Note: SWOT Analysis will be Provided for The Top 5 Players)